(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Vaccines
This study will examine the safety and effectiveness of a meningitis vaccine (Menactra) when given at the same time as the standard diphtheria, tetanus, pertussis vaccine (Daptacel) in children 4-6 years old. Your child may be eligible for the study if your child is healthy and has no history of serious medical problems and has not yet received his/her fifth booster dose of diphtheria, tetanus, pertussis vaccine.
Research sites are located throughout the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat372.html.
-----
Peripheral Arterial Occlusive Disease
This study will evaluate the safety and effectiveness of the study drug intra-thrombus alfimeprase 0.3mg/kg compared with a non-medicinal placebo in people with acute peripheral arterial occlusion (PAO). Volunteers must be 18 or older with arteriographically-confirmed acute PAO of the lower extremity with onset of symptoms within 14 days, must not have a history of significant acute or chronic kidney disease that would preclude contrast angiography, and must not have a known allergy to contrast agents.
The research site is in Little Rock, Ark.
More information
Please see http://www.centerwatch.com/patient/studies/cat204.html.
-----
Fibromyalgia
If you have pain associated with fibromyalgia, you may be eligible for this research study of an investigational medication. Qualified candidates 18-70 will receive study-related examinations, lab work, and study medication at no cost, and may be eligible for travel expense compensation.
The research site is in Columbus, Ohio.
More information
Please see http://www.centerwatch.com/patient/studies/cat218.html.
-----
Copyright 2006 Thomson CenterWatch. All rights reserved.
